Cardiac Implant Devices Market By Devices 2023 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Cardiac implant devices market
Cardiac Implant Devices Market: By Devices (CRT, ICD, ICP, Coronary Stents [DES, BMS, Bio-Absorbable], Heart Valves, TAVI); By Geography - (2018-2023)
Report Code : HCR 0032
Updated Date: 10 June, 2018  
18

Copies sold

    Client Rating

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
1.  Market Overview
2. Executive Summary
3. Cardiac Implant Devices Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User profiling
      3.2.3. Patent Analysis
      3.2.4. Top 5 Financials Analysis
4. Cardiac Implant Devices Market Forces
   4.1. Market Drivers
   4.2. Market Constraints
   4.3. Market Challenges
   4.4. Attractiveness of the Industry
      4.4.1. Power of Suppliers
      4.4.2. Power of Customers
      4.4.3. Threat of New entrants
      4.4.4. Threat of Substitution
      4.4.5. Degree of Competition
5. Cardiac Implant Devices Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Cardiac Implant Devices Market – By Devices
   6.1. Cardiac Resynchronization Therapy Devices (CRTs)
   6.2. Implantable Cardioverter Defibrillators (ICDs)
   6.3. Implantable Cardiac Pacemakers (ICPs)
   6.4. Coronary Stents
   6.5. Heart value Replacement/ Repair Devices
   6.6. TAVR (Transactheter Aortic Value Replacement) Valves
   6.7. Watchman implant device
   6.8. Implantable cardiac loop recorder
   6.9. Ventricular Assist Devices (VADs)
   6.10. Catheter ablation
   6.11. Others
7. Cardiac Implant Devices Market – By Disease Conditions
   7.1. Myocardial Ischemia
      7.1.1. Acute Myocardial Infarction
   7.2. Arrhythmias
      7.2.1. Atrial Fibrillation
      7.2.2. Ventricular Fibrillation
      7.2.3. Ventricular Tachycardia
   7.3. Congestive Heart Failure (CHF)
   7.4. Angina Pectoris (AP)
      7.4.1. Stable Angina
      7.4.2. Unstable Angina
   7.5. Cardiomyopathy
   7.6. Aortic Aneurism
   7.7. Others
8. Cardiac Implant Devices Market – By Procedure
   8.1. Introduction 
   8.2. Cardiac Resynchronization Therapy (CRT)
   8.3. Open heart surgery
   8.4. Angioplasty
   8.5. Bypass
   8.6. Heart Valve Repair or Replacement
   8.7. Others
9. Food diagnostic equipment and consumables Market - By Geography
   9.1. North America 
      9.1.1. U.S.  
      9.1.2. Canada 
      9.1.3. Mexico 
      9.1.4. Rest of North America
   9.2. South America 
      9.2.1. Brazil 
      9.2.2. Venezuela
      9.2.3. Argentina
      9.2.4. Ecuador
      9.2.5. Peru
      9.2.6. Colombia 
      9.2.7. Costa Rica
      9.2.8. Rest of South America
   9.3. Europe
      9.3.1. U.K 
      9.3.2. Germany 
      9.3.3. Italy 
      9.3.4. France
      9.3.5. Netherlands
      9.3.6. Belgium
      9.3.7. Spain
      9.3.8. Denmark
      9.3.9. Rest of Europe
   9.4. APAC
      9.4.1. China 
      9.4.2. Australia 
      9.4.3. South Korea
      9.4.4. India
      9.4.5. Taiwan
      9.4.6. Malaysia
      9.4.7. Hong Kong  
      9.4.8. Rest of APAC
   9.5. Middle East& Africa 
      9.5.1. Israel
      9.5.2. South Africa
      9.5.3. Saudi Arabia
   9.6. Rest of Middle East and Africa
10. Market Entropy
   10.1. New Product Launches
   10.2. M&As, Collaborations, JVs, Partnership
11. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   11.1. Abbott Vascular Inc.
   11.2. Medtronic, Inc.
   11.3. Biotronik, Inc.
   11.4. Bentley InnoMed GmbH
   11.5. Elestim-Cardio
   11.6. Cardioelectronica GmbH
   11.7. Qualimed Innovative Medizinprodukte Gmbh
   11.8. Medico S.p.A
   11.9. Lepu Medical Technology
   11.10. Boston Scientific Corporation
*More than 10 Companies are profiled in this Research Report*
"*Financials would be provided on a best efforts basis for private companies"
12. Appendix
   12.1. Abbreviations
   12.2. Sources
   12.3. Research Methodology
   12.4. Bibliography
   12.5. Compilation of Expert Insights
   12.6. Disclaimer
Cardiac implant devices is valued $30,539million in the year 2017 and is expected to grow at a CAGR of 12.5% from 2018-2023.Cardiac implant devices is segmented based on the type of devices in which coronary stunts is having the highest market share in the year 2017 which is valued $9,542 million in the year 2017 and is anticipated to grow at a CAGR of 11.6% from 2018-2023, followed by ICDs which is valued $7,327 million in the year 2017 and is expected to grow at a CAGR of 13.0% from 2018-2023.Increase in the number of elderly people with increased chronic disease will drive the market for cardiac implant devices.
What is Cardiac Implant Devices Market?
Cardiac implant devices are used to treat long term heart conditions such as heart failure and other heart dysfunctions.Implanting devices into the patient’s body is the second stage of the cardiac treatment.Oral medication is considered first and then the devices are implanted into the patient’s body.This cardiac implant devices are segmented based on the device types in which ICDs are considered as the most commonly used device.Advancements in ICD devices are improving the cardiac treatments.


Cardiac Implantable Devices Market

Market Research and Market Trends of Cardiac Implant Device Market
  • Cardio vascular device research laboratory is actively involved in the research and development of new medical devices.Their main focus of area include heart failure medical devices and wireless medical devices monitoring system.
  • MoMe Kardia device is a wearable device used for monitoring the patient condition and the recorded information is continuously stream to cloud.This device gives an alert message if there is any disturbance in the patient condition which helps to address them quickly.
  • Centers for Medicare and Medicaid service (CMS) has proposed changes in ICD device with advanced technology.The advancement in technology in ICD device is a battery powered device placed under the skin of the patient that keeps a track of the person’s heart rate.Thin wires connect the ICD to heart.If there is any abnormal heart rhythm detected the device will deliver an electronic shock to restore a normal heart beat.This device can prevent a patient from sudden deaths.
  • ICD has transformed to use an advanced technology by using Medtronic care link monitor device which is a small convenient device that allows patients to gather information by holding an antenna over the implanted cardiac device.This data is automatically downloaded by the monitor and sent through an internet connection.Clinicians can access the patient’s data by logging onto a website from anywhere.
  • Implantable drug delivery system is a device which is implanted inside the patient’s body which deliver small amount of drugs on a regular basis.By this system the patient does not need to be injected.By using implantable drug delivery system it gives more consistent drug level in blood when compared to using injections which makes the treatment more effective which will also reduce side effects.The dosage of the drug can be adjusted according to the patient requirements.
  • Cardiac system which is a small pacemaker implanted into a patient body which continuously monitor the heartbeat and as soon as AF (Atrial fibrillation) is detected it emits low energy electrical pulse that are hardly felt by the patient.This system does not require any separate set of delivery devices and the system can be switched off and on repetitively as per the patient’s convenience.

Who are the Major Players in Food diagnostic equipment and consumable market?
The companies referred in the market research report includes Ametek Inc, Beckman coulter Inc, Biomerieux Inc, Bio-rad laboratories, Bruker Corporation and many more.

What is our report scope?
The report incorporates in-depth assessment of the competitive landscape, product market sizing, product benchmarking, market trends, product developments, financial analysis, strategic analysis and so on to gauge the impact forces and potential opportunities of the market.Apart from this the report also includes a study of major developments in the market such as product launches, agreements, acquisitions, collaborations, mergers and so on to comprehend the prevailing market dynamics at present and its impact during the forecast period 2018-2024.
All our reports are customizable to your company needs to a certain extent, we do provide 20 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report to your needs.

Key Takeaways from this Report
  • Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
  • Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
  • Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
  • Analyze the sales and distribution channels across key geographies to improve top-line revenues.
  • Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
  • Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
  • Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
List of Tables

Table 1. Product Benchmarking, Coronary Stents. 
Table 2. Product Benchmarking, Implantable Cardiac Pacemakers. 
Table 3. Product Benchmarking, Implantable Cardioverter Defibrillators (ICD). 
Table 4. Product Benchmarking, Cardiac Resynchronization Therapy (CRT). 
Table 5. Product Benchmarking, Heart Valves
Table 6. Product Benchmarking, Transcatheter Aortic Valves Replacement Valves
Table 7. Cardiac Implant Devices Market, Top Five Financial Analysis. 
Table 8. Cost Comparison of Cardiac Surgical Treatment. 
Table 9. Cardiac Implants Devices Market, by Devices, by Value, 2014 – 2020 ($Million)
Table 10. Cardiac Implants Devices Market, by Devices, by Volume, 2014 – 2020 (Million Units)
Table 11. Cardiac Implants Devices Market, CRT, by Region, by Value, 2014 – 2020 ($Million).
Table 12. Cardiac Implants Devices Market Value, ICD, by Region, by Value, 2014 – 2020 ($Million)
Table 13. Cardiac Implant Devices Market, Pacemakers, by Region, by Value, 2014 – 2020 ($Million)
Table 14. Cardiac Implants Devices Market, Coronary Stents, by Region, by Value, 2014 – 2020 ($Million). 
Table 15. Cardiac Implant Devices Market, Heart Valves, by Region, by Value, 2014 – 2020 ($Million)
Table 16. Cardiac Implant Devices Market, TAVI Valves, by Region, by Value, 2014 – 2020 ($Million)
Table 17. Cardiac Implants Devices Market, By Regions, by Value, 2014-2020 ($Million).
Table 18. Cardiac Implants Devices Market, By Regions, by Volume, 2014-2020 (Million Units)
Table 19. Cardiac Implants Devices Market, Americas, by Value, 2014-2020 ($Million)
Table 20. Cardiac Implants Devices Market, Americas, by Volume, 2014-2020 (Million Units).
Table 21. Cardiac Implants Devices Market, Americas, by Devices, by Value, 2014-2020 ($Million)
Table 22. Cardiac Implant Devices Market, by Value, Europe, 2014-2020 ($Million). 
Table 23. Cardiac Implant Devices Industry, by Volume, Europe, 2014-2020 (Million Units).
Table 24. Cardiac Implant Devices Industry, by Devices, Europe, 2014-2020 ($Million).
Table 25. Cardiac Implant Devices Industry, by Value, Asia-Pacific, 2014-2020 ($Million).
Table 26. Cardiac Implant Devices Industry, by Volume, Asia-Pacific, 2014-2020 (Million Units)
Table 27. Cardiac Implant Devices Industry, by Device, Asia-Pacific, 2014-2020 ($Million).
Table 28. Cardiac Implant Devices Industry, by Value, Row, 2014-2020 ($Million).
Table 29. Cardiac Implant Devices Industry, Row, by Volume, 2014-2020 (Million Units).
Table 30. Cardiac Implant Devices Industry, by Device, Row, 2014-2020 ($Million).
Table 31. Cardiac Implant Devices Industry: Key Product Launches.
Table 32. Cardiac Implant Devices Industry: Key Partnerships.
Table 33. Cardiac Implant Devices Market: Key Acquisitions. 
Table 34. Abbott Vascular Inc., Products. 
Table 35. Abbott Vascular Inc., Developments
Table 36. Medtronic PLC, Products. 
Table 37. Medtronic PLC, Developments. 
Table 38. BIOTRONIK Inc., Products. 
Table 39. BIOTRONIK Inc., Developments. 
Table 40. COOK Medical INC, Products. 
Table 41. COOK Medical INC, Developments. 
Table 42. CARDIONOVUM GMBH, Products. 
Table 43. CARDIONOVUM GMBH, Developments. 
Table 44. ALVIMEDICA Health Investments INC, Products. 
Table 45. ALVIMEDICA Health Investments INC, Developments. 
Table 46. AMARANTH Medical, Products. 
Table 47. AMARANTH Medical, Developments. 
Table 48. STENSYS SA, Products. 
Table 49. STENSYS SA, Developments
Table 50. HEXACATH, Products. 
Table 51. OPTO Circuits (India) Ltd., Products. 
Table 52. OPTO Circuits (India) Ltd., Developments. 
Table 53. JENAVALVE Technology, Products. 
Table 54. MICROPORT Scientific Corporation, Products. 
Table 55. MICROPORT Scientific Corporation, Developments. 
Table 56. TRYTON Medical, Inc., Products. 
Table 57. TRYTON Medical, Inc., Developments. 
Table 58. BENTLEY INNOMED GMBH, Products. 
Table 59. BENTLEY INNOMED GMBH, Developments. 
Table 60. ELESTIM-Cardio, Products. 
Table 61. Cardio electronica, Products. 
Table 62. QUALIMED Innovative MEDIZINPRODUKTE GMBH, Products. 
Table 63. Medico S.P.A, Products. 
Table 64. LEPU Medical Technology Co., Ltd., Products. 
Table 65. LEPU Medical Technology Co., Ltd., Developments. 
Table 66. Boston Scientific Corporation, Products. 
Table 67. Boston Scientific Corporation, Developments. 
Table 68. St. Jude Medical, Inc., Products. 
Table 69. St. Jude Medical, Inc., Developments
Table 70. Edwards Life sciences Corporation, Products. 
Table 71. Edwards Life sciences Corporation, Developments. 
Table 72. MERIL Life sciences Pvt. Ltd., Products
Table 73. MERIL Life sciences Pvt. Ltd., Developments. 
Table 74. EUCATECH AG, Products. 
Table 75. Biosensors International Group, Ltd, Products. 
Table 76. Biosensors International Group, Ltd, Developments. 
Table 77. Japan Lifeline Co., Ltd., Products. 
Table 78. Japan Lifeline Co., Ltd., Developments. 
Table 79. SORIN S.P.A, Products. 
Table 80. SORIN S.P.A, Developments


List of Figures

Figure 1. Cardiac Implant Devices, Disease Conditions. 
Figure 2. Cardiac Implant Devices Market, by Devices
Figure 3. Cardiac Implant Devices Industry Revenue – by Geographic Region, 2014 (%).
Figure 4. Cardiac Implant Devices Industry, Market Share Analysis, 2014 (%)
Figure 5. Cardiac Implant Devices Industry, Patent Analysis.
Figure 6. Cardiac Implant Devices Industry - Value Chain Analysis.
Figure 7. Cardiac Implant Devices Industry, Product/Market Lifecycle Analysis - ICDS, CRTS, Heart Valve Prosthetics and TAVR Valves
Figure 8. Cardiac Implants Devices Market, Product/Market Lifecycle Analysis – Pacemakers, Coronary Stents.
Figure 9. Cardiac Implant Devices Industry Revenue – by Geographic Region, 2014 (%).
Figure 10. Cardiac Implant Devices Market Strategy, 2012-15 (%). 
Figure 11. Abbott Vascular Inc.: Financial Performance, Total Revenues 2012-2014, ($Billion)
Figure 12. Abbott Vascular Inc.: Total Revenue, by Region, 2014 (%). 
Figure 13. Abbott Vascular Inc.: Total Revenue, by Segments, 2014 (%). 
Figure 14. Financial Performance, Total Revenues, 2010-2014, ($Billion). 
Figure 15. Medtronic Plc. Total Revenue, by Region, 2014 (%). 
Figure 16. Medtronic Plc. Total Revenue, by Segments, 2014 (%). 
Figure 17. OPTO Circuits Limited: Financial Performance, 2012-2014, ($Billion). 
Figure 18. OPTO Circuits Limited: Total Revenue, by Region, 2013 (%). 
Figure 19. OPTO Circuits Limited: Total Revenue, by Segments, 2013 (%). 
Figure 20. MICROPORT Scientific Corporation: Financial Performance, 2010-2014, ($Billion). 
Figure 21. MICROPORT Scientific Corporation: Total Revenue, by Segment, 2014(%)
Figure 22. MICROPORT Scientific Corporation: Total Revenue, by Region, 2014(%). 
Figure 23. Boston Scientific Corporation: Financial Performance, 2010-2014, ($Billion)
Figure 24. Boston Scientific Corporation: Total Revenue, by Segments, 2014 (%). 
Figure 25. Boston Scientific Corporation: Total Revenue, by Region, 2014 (%). 
Figure 26. St. Jude Medical, Inc.: Financial Performance, 2011-2014, ($Billion). 
Figure 27. St. Jude Medical, Inc.: Total Revenue, by Region, 2014 (%). 
Figure 28. St. Jude Medical, Inc.: Total Revenue, by Segments, 2014 (%). 
Figure 29. Edwards Life sciences Corporation: Financial Performance, 2011-2014, ($Billion). 
Figure 30. Edwards Life sciences Corporation, Total Revenue, by Segments, 2014 (%). 
Figure 31. Edwards Life sciences Corporation, Total Revenue, by Region, 2014 (%)
Figure 32. Biosensors International Group, Ltd.: Financial Performance, 2011-2014, ($Million). 
Figure 33. Biosensors International Group, Ltd.: Total Revenue, by Segment, 2014 (%). 
Figure 34. Biosensors International Group, Ltd.: Total Revenue, by Region, 2014 (%). 
Figure 35. Japan Lifeline Co., Ltd.: Financial Performance, 2011-2014, ($Million). 
Figure 36. Japan Lifeline Co., Ltd.: Total Revenue, by Segments, 2014 (%). 
Figure 37. Financial Performance, 2011-2014, ($Billion). 
Figure 38. SORIN S.P.A. Total Revenue, by Region, 2014 (%). 
Figure 39. SORIN S.P.A. Total Revenue, by Segments, 2014 (%)


Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll